{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:19:34Z","timestamp":1765783174689,"version":"3.48.0"},"reference-count":35,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,11,7]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Trastuzumab has been widely used in breast cancers. Despite its efficacy, trastuzumab-induced pneumonitis (TIP) remains a rare yet potentially fatal complication. While corticosteroids are the mainstay of treatment, steroid-refractory cases pose significant challenges due to the lack of standardised guidelines and limited data on additional therapies. We describe a case of grade 4 TIP in a female in her early 70s, initially managed with steroids and intravenous immunoglobulin, resulting in minimal clinical improvement. Due to the lack of response, advanced immunosuppressive therapy with infliximab was initiated which led to a marked improvement in her condition. This suggests that infliximab may be used to treat severe, corticosteroid-resistant TIP, particularly in cases when conventional therapy is ineffective. The findings obtained here urge additional research to better characterise further interventions like infliximab in TIP therapy and highlight the need for updated guidelines that incorporate advanced immunosuppressive medicines.<\/jats:p>","DOI":"10.1136\/bcr-2025-266776","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:15:20Z","timestamp":1765782920000},"page":"e266776","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Severe trastuzumab-induced pneumonitis refractory to steroid therapy"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9192-5110","authenticated-orcid":false,"given":"Dua","family":"Azim","sequence":"first","affiliation":[{"name":"Internal medicine, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-633X","authenticated-orcid":false,"given":"Aditya","family":"Sanjeevi","sequence":"additional","affiliation":[{"name":"Internal medicine, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Idoate","family":"Domench","sequence":"additional","affiliation":[{"name":"Rochester General Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Imran","sequence":"additional","affiliation":[{"name":"Rochester General Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"2025121423150924000_18.12.e266776.1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05754-8"},{"key":"2025121423150924000_18.12.e266776.2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007409","article-title":"Corticosteroid-resistant immune-related adverse events: a systematic review","volume":"12","author":"Daetwyler","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2025121423150924000_18.12.e266776.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"key":"2025121423150924000_18.12.e266776.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(03)00031-6"},{"key":"2025121423150924000_18.12.e266776.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115022"},{"key":"2025121423150924000_18.12.e266776.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052122"},{"key":"2025121423150924000_18.12.e266776.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052306"},{"key":"2025121423150924000_18.12.e266776.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00035502"},{"key":"2025121423150924000_18.12.e266776.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00907.x"},{"key":"2025121423150924000_18.12.e266776.10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/030089160809400516","article-title":"A case of interstitial pneumonitis associated with Guillain-Barr\u00e9 syndrome during administration of adjuvant trastuzumab","volume":"94","author":"Bettini","year":"2008","journal-title":"Tumori"},{"key":"2025121423150924000_18.12.e266776.11","first-page":"237","article-title":"Fatal pneumonitis after treatment with docetaxel and trastuzumab","volume":"67","author":"Kuip","year":"2009","journal-title":"Neth J Med"},{"key":"2025121423150924000_18.12.e266776.12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10549-008-9966-8","article-title":"Life-threatening interstitial lung disease associated with trastuzumab: case report","volume":"113","author":"Pepels","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2025121423150924000_18.12.e266776.13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1579-2129(10)70104-X","article-title":"Organizing Pneumonia Associated with the Use of Trastuzumab","volume":"46","author":"Taus-Garc\u00eda","year":"2010","journal-title":"Archivos de Bronconeumolog\u00eda ((English Edition))"},{"key":"2025121423150924000_18.12.e266776.14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000326063","article-title":"Delayed Paclitaxel-trastuzumab-induced interstitial pneumonitis in breast cancer","volume":"4","author":"Abulkhair","year":"2011","journal-title":"Case Rep Oncol"},{"key":"2025121423150924000_18.12.e266776.15","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1365-4632.2012.05788.x","article-title":"Radiation recall dermatitis and pneumonitis induced by trastuzumab (Herceptin\u00ae)","volume":"53","author":"Lee","year":"2014","journal-title":"Int J Dermatol"},{"key":"2025121423150924000_18.12.e266776.16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3892\/mco.2016.1113","article-title":"Interstitial lung disease associated with trastuzumab monotherapy: A report of 3 cases","volume":"6","author":"Sugaya","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"2025121423150924000_18.12.e266776.17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1159\/000477340","article-title":"Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review","volume":"10","author":"Costa","year":"2017","journal-title":"Case Rep Oncol"},{"key":"2025121423150924000_18.12.e266776.18","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1177\/1078155218813716","article-title":"Interstitial pneumonitis associated with trastuzumab emtansine","volume":"25","author":"Alkan","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2025121423150924000_18.12.e266776.19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014017","article-title":"Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer","volume":"98","author":"Jin","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025121423150924000_18.12.e266776.20","unstructured":"Mirrakhimov A , Saeed AI . Delayed onset trastuzumab induced pneumonitis. American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX; May 2019 doi:10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A1509 Available: https:\/\/www.atsjournals.org\/doi\/book\/10.1164\/ajrccm-conference.2019.A39"},{"key":"2025121423150924000_18.12.e266776.21","doi-asserted-by":"crossref","first-page":"A1537","DOI":"10.1016\/j.chest.2019.08.1357","article-title":"TRASTUZUMAB-INDUCED INTERSTITIAL PNEUMONITIS: DIAGNOSTIC AWARENESS","volume":"156","author":"Chen","year":"2019","journal-title":"Chest"},{"key":"2025121423150924000_18.12.e266776.22","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243881","article-title":"Acute eosinophilic pneumonia: a fatal reaction to ado-trastuzumab","volume":"14","author":"LaMorte","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2025121423150924000_18.12.e266776.23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/japt.japt_5_22","article-title":"Drug-Induced Interstitial Pneumonitis in a Case of Breast Malignancy","volume":"5","author":"Murugesan","year":"2022","journal-title":"J Assoc Pulmonol Tamil Nadu"},{"key":"2025121423150924000_18.12.e266776.24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.24911\/ejmcr\/173-1637238300","article-title":"Toxic pneumonitis induced by trastuzumab as a potentially fatal event: a case report","volume":"6","author":"Fontes","year":"2022","journal-title":"EJMCR"},{"key":"2025121423150924000_18.12.e266776.25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jor4030013","article-title":"Trastuzumab-Induced Organising Pneumonia in Breast Cancer Patient","volume":"4","author":"Dixit","year":"2024","journal-title":"JoR"},{"key":"2025121423150924000_18.12.e266776.26","article-title":"Trastuzumab-Induced Interstitial Pneumonitis","volume":"15","author":"Errisuriz","year":"2023","journal-title":"Cureus"},{"key":"2025121423150924000_18.12.e266776.27","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omad135","article-title":"Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancer","volume":"2023","author":"Yasuda","year":"2023","journal-title":"Oxf Med Case Reports"},{"key":"2025121423150924000_18.12.e266776.28","article-title":"Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report","volume":"5","author":"Nam","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"2025121423150924000_18.12.e266776.29","doi-asserted-by":"crossref","DOI":"10.5339\/qmj.2024.qitc.12","article-title":"Trastuzumab\/paclitaxel-induced pneumonitis in breast cancer","volume":"2024","author":"Al-Tikrity","year":"2024","journal-title":"Qatar Med J"},{"key":"2025121423150924000_18.12.e266776.30","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.ctrv.2022.102378","article-title":"Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease\/pneumonitis-Focus on proactive monitoring, diagnosis, and management","volume":"106","author":"Swain","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"2025121423150924000_18.12.e266776.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.06.024"},{"key":"2025121423150924000_18.12.e266776.32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.36401\/JIPO-20-22","article-title":"Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis","volume":"3","author":"Lai","year":"2020","journal-title":"J Immunother Precis Oncol"},{"key":"2025121423150924000_18.12.e266776.33","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0400-4"},{"key":"2025121423150924000_18.12.e266776.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"2025121423150924000_18.12.e266776.35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10263"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:15:34Z","timestamp":1765782934000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,14]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bcr-2025-266776"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266776","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}